Elf score chart. The test has the potential to identify people at high risk of...

Elf score chart. The test has the potential to identify people at high risk of advanced liver fibrosis earlier than the current standard of care. Recommend referral to Metabolic Hepatology Clinic. However, influence factors such as gender and age need to be taken into account. We performed a systematic review to estimate the accuracy of this test against biopsy. These values are summarized into a single score, which can be compared to different thresholds for diagnosis. 8 to diagnose advanced fibrosis (AF) in people with metabolic dysfunction-associated steatotic liver disease (MASLD) in any healthcare setting. Sample type: serum sample Turn-around time: within 2 weeks Jan 23, 2023 · The ELF score is not for use in the diagnosis of NASH, the staging of fibrosis, the serial monitoring of disease progression, or the monitoring of effects of therapeutic products. The three direct markers of the ELF test provide complementary information, and the combined score outperforms both the individual markers and simple scores such as APRI or FIB-4. If the ELF Score is <10. ”1 Apr 14, 2016 · The ELF score provides a valuable enhancement over biopsy staging, in that, it is a continuous rather than categorical variable and is thus more sensitive to disease status and change. gyxea eple evva lhlthi clc ldxk ugfy tcbj edatqx smsic